Deliverable report on 2.4 - Consensus Meetings

<p>Deliverable report on 1st and 2nd Consensus Meetings. Published by Workpackage 2 of the Europain project.</p> <p>The EuroPain project has received support from the Innovative Medicines Initiative Joint Undertaking under grant agreement n° 115007, resources for which are composed of financial contribution from the European Union's Seventh Framework Programme (FP7/20072013) and EFPIA companies’ in kind contribution.This is a unique public-private partnership designed by the European Commission and European Federation of Pharmaceutical Industries and Associations (EFPIA). It is a pan-European collaboration that brings together large biopharmaceutical companies, small- and medium-sized enterprises (SMEs), patient organisations, academia, hospitals and public authorities.</p

Deliverable report on 2.2c - Validation of burrowing deficit in CFA model

<p>Deliverable report 2.2c on validation of burrowing deficit as a novel pain outcome measure in rats. Published by Workpackage 2 of the Europain project.</p> <p>The EuroPain project has received support from the Innovative Medicines Initiative Joint Undertaking under grant agreement n° 115007, resources for which are composed of financial contribution from the European Union's Seventh Framework Programme (FP7/20072013) and EFPIA companies’ in kind contribution.This is a unique public-private partnership designed by the European Commission and European Federation of Pharmaceutical Industries and Associations (EFPIA). It is a pan-European collaboration that brings together large biopharmaceutical companies, small- and medium-sized enterprises (SMEs), patient organisations, academia, hospitals and public authorities.</p

Deliverable report on 2.1bii - Oxaliplatin induced cold hypersensitivity in the mouse

<p>Deliverable report on 2.1bii - Development and characterisation of a new mouse model of chemotherapy-induced neuropathy. Published by Workpackage 2 of project Europain. </p> <p>The EuroPain project has received support from the Innovative Medicines Initiative Joint Undertaking under grant agreement n° 115007, resources for which are composed of financial contribution from the European Union's Seventh Framework Programme (FP7/20072013) and EFPIA companies’ in kind contribution.This is a unique public-private partnership designed by the European Commission and European Federation of Pharmaceutical Industries and Associations (EFPIA). It is a pan-European collaboration that brings together large biopharmaceutical companies, small- and medium-sized enterprises (SMEs), patient organisations, academia, hospitals and public authorities.</p

Deliverable report 2.1bi antiretroviral neuropathy model

<p>Deliverable report on 2.1bi - antiretroviral neuropathy in the rat. Published by Workpackage 2 of the Europain project.</p> <p>The EuroPain project has received support from the Innovative Medicines Initiative Joint Undertaking under grant agreement n° 115007, resources for which are composed of financial contribution from the European Union's Seventh Framework Programme (FP7/20072013) and EFPIA companies’ in kind contribution.This is a unique public-private partnership designed by the European Commission and European Federation of Pharmaceutical Industries and Associations (EFPIA). It is a pan-European collaboration that brings together large biopharmaceutical companies, small- and medium-sized enterprises (SMEs), patient organisations, academia, hospitals and public authorities.</p

Refined rat models of HIV antiretroviral drugs stavudine and indinavir induced peripheral neuropathy

<p>Protocol manuscript describing rat models of neuropathic pain caused by antiretroviral agents stavudine and indinavir. Published by Workpackage 2 of the Europain project.</p> <p>The EuroPain project has received support from the Innovative Medicines Initiative Joint Undertaking under grant agreement n° 115007, resources for which are composed of financial contribution from the European Union's Seventh Framework Programme (FP7/20072013) and EFPIA companies’ in kind contribution.This is a unique public-private partnership designed by the European Commission and European Federation of Pharmaceutical Industries and Associations (EFPIA). It is a pan-European collaboration that brings together large biopharmaceutical companies, small- and medium-sized enterprises (SMEs), patient organisations, academia, hospitals and public authorities.</p

Deliverable report on 2.2d - Protocols for measuring spontaneous activity in peripheral afferent C-fibres in various models of neuropathic pain in rats

<p>Deliverable report on 2.2d - </p> <p><strong>Protocols for measuring spontaneous activity in peripheral afferent C-fibres in various models of Neuropathic Pain in rats.  Published by Workpackage 2 of the Europain project.</strong></p> <p><br>The EuroPain project has received support from the Innovative Medicines Initiative Joint Undertaking under grant agreement n° 115007, resources for which are composed of financial contribution from the European Union's Seventh Framework Programme (FP7/20072013) and EFPIA companies’ in kind contribution.This is a unique public-private partnership designed by the European Commission and European Federation of Pharmaceutical Industries and Associations (EFPIA). It is a pan-European collaboration that brings together large biopharmaceutical companies, small- and medium-sized enterprises (SMEs), patient organisations, academia, hospitals and public authorities.</p

Deliverable report on 2.1c - a rat model of NGF-induced peripheral sensitisation

<p>Deliverable report 2.1c on a rat model of NGF-induced peripheral sensitisation published by Workpackage 2 of the Europain project.</p> <p>The EuroPain project has received support from the Innovative Medicines Initiative Joint Undertaking under grant agreement n° 115007, resources for which are composed of financial contribution from the European Union's Seventh Framework Programme (FP7/20072013) and EFPIA companies’ in kind contribution.This is a unique public-private partnership designed by the European Commission and European Federation of Pharmaceutical Industries and Associations (EFPIA). It is a pan-European collaboration that brings together large biopharmaceutical companies, small- and medium-sized enterprises (SMEs), patient organisations, academia, hospitals and public authorities.</p

Deliverable report on 2.2b. Protocols for measuring disturbance of circadian rhythm and cognitive function in pain models

<p>Deliverable report 2.2b - Protocols for measuring disturbance of circadian rhythm and cognitive function in pain models.  Published by Workpackage 2 of project Europain.</p> <p>The EuroPain project has received support from the Innovative Medicines Initiative Joint Undertaking under grant agreement n° 115007, resources for which are composed of financial contribution from the European Union's Seventh Framework Programme (FP7/20072013) and EFPIA companies’ in kind contribution.This is a unique public-private partnership designed by the European Commission and European Federation of Pharmaceutical Industries and Associations (EFPIA). It is a pan-European collaboration that brings together large biopharmaceutical companies, small- and medium-sized enterprises (SMEs), patient organisations, academia, hospitals and public authorities.</p

Spinal cord contusion: A traumatic rat model of spinal cord injury and at-level hypersensitivity

<p>Protocol manuscript describing the spinal cord contusion model of central neuropathic pain in the rat. Published by Workpackage 2 of the EuroPain project.</p> <p> </p> The EuroPain project has received support from the Innovative Medicines Initiative Joint Undertaking under grant agreement n° 115007, resources for which are composed of financial contribution from the European Union's Seventh Framework Programme (FP7/20072013) and EFPIA companies’ in kind contribution.This is a unique public-private partnership designed by the European Commission and European Federation of Pharmaceutical Industries and Associations (EFPIA). It is a pan-European collaboration that brings together large biopharmaceutical companies, small- and medium-sized enterprises (SMEs), patient organisations, academia, hospitals and public authorities

Tibial Nerve Transection (TNT) Model of Neuropathic Pain in the Rat

<p>Protocol manuscript describing tibial nerve transection rat model of neuropathic pain. Published by Workpackage 2 of the EuroPain project.</p> <p>The EuroPain project has received support from the Innovative Medicines Initiative Joint Undertaking under grant agreement n° 115007, resources for which are composed of financial contribution from the European Union's Seventh Framework Programme (FP7/20072013) and EFPIA companies’ in kind contribution.This is a unique public-private partnership designed by the European Commission and European Federation of Pharmaceutical Industries and Associations (EFPIA). It is a pan-European collaboration that brings together large biopharmaceutical companies, small- and medium-sized enterprises (SMEs), patient organisations, academia, hospitals and public authorities.</p